DNA sequencing by mass spectrometry

• US 5,547,835 A
• Filed: 01/06/1994
• Issued: 08/20/1996
• Est. Priority Date: 01/07/1993
• Status: Expired due to Term

• Current Assignee: Agena Bioscience Inc. (Mesa Laboratories Inc.)
• Original Assignee: Sequenom Incorporated (Laboratory Corporation Of America Holdings)
• Inventors: Koster, Hubert
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): TRAN, PAUL
• Application Number:
  US08/178,216
• Time in Patent Office: 957 Days
• Field of Search: 435/6, 435/91.1, 435/291, 935/77, 935/78, 536/25.3, 536/25.4, 436/173
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6872 involving mass spectrometry
• CPC Class Codes: C12Q 2537/113 Heteroduplex formation
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2563/167 Mass label
• CPC Class Codes: C12Q 2565/627 being a mass spectrometer
• CPC Class Codes: G01N 35/1067 for transfer to or from containers having different spacing
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]
• CPC Class Codes: Y10T 436/24 Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
• CPC Class Codes: Y10T 436/25 including sample preparation

Abstract

The invention describes a new method to sequence DNA. The improvements over the existing DNA sequencing technologies are high speed, high throughput, no electrophoresis and gel reading artifacts due to the complete absence of an electrophoretic step, and no costly reagents involving various substitutions with stable isotopes. The invention utilizes the Sanger sequencing strategy and assembles the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses using mass spectrometry, as for example, MALDI or ES mass spectrometry. A further increase in throughput can be obtained by introducing mass-modifications in the oligonucleotide primer, chain-terminating nucleoside triphosphates and/or in the chain-elongating nucleoside triphosphates, as well as using integrated tag sequences which allow multiplexing by hybridization of tag specific probes with mass differentiated molecular weights.

Claims

1. A method for determining the sequence of a nucleic acid, comprising the steps of:

a) generating at least two conditioned, base-specifically terminated nucleic acid fragments from a nucleic acid to be sequenced;

b) determining the molecular weight value of each base-specifically terminated fragment by mass spectrometry, wherein the molecular weight values of at least two base-specifically terminated fragments are determined concurrently; and

c) determining the sequence of the nucleic acid by aligning the base-specifically terminated nucleic acid fragments according to molecular weight.

2. The method according to claim 1 wherein the nucleic acid fragments are purified before the step of determining the molecular weight values by mass spectrometry.

3. The method according to claim 2 wherein the nucleic acid fragments are purified, comprising the steps of:

i) reversibly immobilizing the nucleic acid fragments on a solid support; and

ii) washing out all remaining reactants and by-products.

4. The method according to claim 3, further comprising the step of removing the nucleic acid fragments from the solid support.

5. The method according to claim 3, wherein each fragment is coupled by the linking group (L) to a functionality (L'"'"') on the support creating a temporary and cleavable attachment of the nucleic acid fragments to the support.

6. The method according to claim 5, wherein the base-specifically terminated nucleic acid fragments are cleaved from the solid support prior to mass spectrometry.

7. The method according to claim 5, wherein the base-specifically terminated nucleic acid fragments are cleaved from the solid support during mass spectrometry.

8. The method according to claim 5, wherein the temporary and cleavable attachment can be cleaved enzymatically, chemically or physically.

9. The method according to claim 8, wherein the temporary and cleavable attachment is selected from the group consisting of a photocleavable bond, a bond based on strong electrostatic interaction, a tritylether bond, a β

-benzoylpropionyl group, a levulinyl group, a disulfide bond, an arginine/arginine bond, a lysine/lysine bond, a pyrophosphate bond, and a bond created by Watson-Crick base pairing.

10. The method according to claim 1, wherein step a), the nucleic acid fragments are conditioned by cation exchange.

11. The method according to claim 1, wherein step a), the nucleic acid fragments are conditioned by mass modification.

12. The method according to claim 11, wherein each nucleic acid fragment is synthesized using a nucleic acid primer;

in the presence of chain-terminating and chain-elongating deoxynucleotides; and

wherein at least one chain-elongating deoxynucleotide is selected from the group consisting of deoxyadenosine triphosphate dATP, deoxythymidine triphosphate dTTP, deoxyguanosine triphosphate dGTP, deoxycytidine triphosphate dCTP, deoxyinosine triphosphate dITP, a 7-deazadeoxyguanosine triphosphate c⁷ dGTP, a 7-deazadeoxyadenosine triphosphate c⁷ dATP, and a 7-deazadeoxyinosine triphosphate c⁷ dITP;

at least one chain-terminating dideoxynucleotide selected from the group consisting of dideoxyadenosine triphosphate ddATP, dideoxythymidine triphosphate ddTTP, dideoxyguanosine triphosphate ddGTP, and dideoxycytidine triphosphate ddCTP; and

a DNA polymerase.

13. The method according to claim 12, wherein the nucleic acid primer further includes a linking group (L) for reversibly immobilizing the primer on a solid support.

14. The method according to claim 11, wherein each nucleic acid fragment is synthesized using chain terminating and chain elongating nucleotides and wherein at least one chain elongating nucleotide is selected from the group consisting of adenosine triphosphate (ATP), uridine triphosphate (UTP), guanosine triphosphate (GTP), cytidine triphosphate (CTP), inosine triphosphate (ITP), a 7-deazaadenosine triphosphate (c⁷ ATP), a 7-deazaguanosine triphosphate (c⁷ GTP), and a 7-deazainosine triphosphate (c⁷ ITP);

and at least one chain-terminating 3'"'"'-deoxynucleotide selected from the group consisting of deoxyadenosine triphosphate 3'"'"'-dATP, deoxyuridine triphosphate 3'"'"'-dUTP, deoxyguanosine triphosphate 3'"'"'-dGTP, and deoxycytidine triphosphate 3'"'"'-dCTP); and

an RNA polymerase.

15. The method according to claim 1, wherein the molecular weight value of each nucleic acid fragment is determined by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS).

16. The method according to claim 1 in which the molecular weight value of each nucleic acid fragment is determined by electrospray mass spectrometry (ES-MS).

17. The method of claim 1, wherein step b) is performed without first performing an electrophoretic separation.

18. A method of claim 1, wherein the base-specifically terminated nucleic acid fragments are conditioned by removing the negative charge from the phosphodiester backbone.

19. A method of claim 1, wherein the base-specifically terminated nucleic acid fragments are conditioned by purification.

20. The method according to claim 1, wherein more than one species of nucleic acid are concurrently sequenced by multiplex mass spectrometric nucleic acid sequencing employing tag probes, nucleic acid primers, chain-elongating nucleotides, and chain-terminating nucleotides, wherein one of the sets of base-specifically terminated fragments is unmodified and the other sets of base-specifically terminated fragments are mass modified, and each of the sets of base-specifically terminated nucleic acid fragments has a sufficient mass difference to be distinguished from the others by mass spectrometry.

21. The method according to claim 20, wherein at least one of the sets of mass-modified base-specifically terminated fragments is modified with a mass-modifying functionality (M) at a heterocyclic base of at least one nucleotide.

22. The method according to claim 21, wherein the heterocyclic base-modified nucleotide is selected from the group consisting of a cytosine nucleotide modified at C-5, a thymine nucleotide modified at C-5, a thymine nucleotide modified at the C-5 methyl group, a uracil nucleotide modified at C-5, an adenine nucleotide modified at C-8, a c⁷ -deazaadenine modified at C-8, a c⁷ -deazaadenine modified at C-7, a guanine nucleotide modified at C-8, a c⁷ -deazaguanine modified at C-8, a c⁷ -deazaguanine modified at C-7, a hypoxanthine modified at C-8, a c⁷ -deazahypoxanthine modified at C-7, and a c⁷ -deazahypoxanthine modified at C-8.

23. The method according to claim 20, wherein at least one of the sets of mass-modified base-specifically terminated nucleic acid fragments is modified with a mass-modifying functionality (M) attached to one or more phosphate moieties of the internucleotidic linkages of the fragments.

24. The method according to claim 20, wherein at least one of the sets of mass-modified base-specifically terminated nucleic acid fragments is modified with a mass-modifying functionality (M) attached to one or more sugar moieties of nucleotides within the set of mass modified base-specifically terminated fragments at at least one sugar position selected from the group consisting of a C-2'"'"' position, an external C-3'"'"' position, and an external C-5'"'"' position.

25. The method according to claim 20, wherein at least one of the sets of mass-modified base-specifically terminated nucleic acid fragments is modified with a mass-modifying functionality (M) attached to the sugar moiety of a 5'"'"'-terminal nucleotide and wherein the mass-modifying function (M) is the linking functionality (L).

26. The method according to claim 20, wherein a mass-modifying functionality (M) is attached to a set of base-specifically terminated nucleic acid fragments subsequent to generating the base-specifically terminated nucleic acid fragments and prior to determining the molecular weight values for the nested fragments by mass spectrometry.

27. The method according to claim 26, wherein the base-specifically terminated nucleic acid fragments are generated using at least one reagent selected from the group consisting of a nucleic acid primer, a chain-elongating nucleotide, a chain-terminating nucleotide, a tag probe which has been modified with a precursor of the mass-modifying functionality, M;

and a subsequent step comprises modifying the precursor of the mass-modifying functionality, M, to generate the mass-modifying functionality, M, prior to mass spectrometric analysis.

28. The method according to claim 20, wherein mass differentiation of the tag probes is achieved by changing the nucleotide composition of at least one of the tag probes and complementary tag sequence in the species of nucleic acid.

29. The method according to claim 20, wherein the tag probes are covalently bound to the corresponding complementary tag sequence prior to mass spectrometric analysis.

30. The method according to claim 29, wherein binding between the tag probes and the corresponding complementary tag sequences is achieved photochemically via photoactivatable groups.

31. A method of sequencing a nucleic acid, comprising the steps of:

a) reversibly linking an oligonucleotide primer to a solid support;

b) generating at least two conditioned, base-specifically terminated nucleic acid fragments;

c) determining the molecular weight value of each nested fragment in each of the four sets of base-specifically terminated fragments by matrix assisted laser desorption/ionization mass spectrometry wherein the molecular weight values of at least two base-specifically terminated fragments are determined concurrently and wherein the nested fragments are cleaved from the solid support by a laser during mass spectrometry; and

d) determining the nucleotide sequence by aligning the base specifically terminated fragments according to molecular weight.

32. The method according to claim 31, wherein the base-specifically terminated fragments are cleaved from the solid support prior to mass spectrometry.

33. The method according to claim 31, wherein the base-specifically terminated fragments are cleaved from the solid support during mass spectrometry.

34. The method according to claim 31, wherein the reversible linkage is a photocleavable bond.

35. The method according to claim 31, wherein step b), the nucleic acid fragments are conditioned by cation exchange.

36. The method according to claim 31, wherein step b), the nucleic acid fragments are conditioned by mass modification.

37. The method according to claim 31, wherein the base-specifically terminated fragments are conditioned by purification.

38. The method according to claim 31, wherein the base-specifically terminated fragments are conditioned by removal of the negative charge of the phosphodiester backbone.

39. A method of multiplex analysis of nucleic acid sequences, comprising the steps of:

a) reversibly linking a nucleic acid primer to a solid support;

b) generating at least two conditioned, base-specifically terminated nucleic acid fragments;

c) determining the molecular weight value of each fragment by matrix assisted laser desorption/ionization mass spectrometry wherein the molecular weight values of at least two base-specifically terminated fragments are determined concurrently and wherein the fragments are cleaved from the solid support by a laser during mass spectrometry; and

d) determining the nucleotide sequence by aligning the fragments according to molecular weight;

wherein at least one reagent selected from a group consisting of, a nucleic acid primer, a chain-elongating nucleotide, and a chain-terminating nucleotide which has been mass-modified;

wherein each set of base-specifically terminated fragments has a sufficient mass difference from the other sets of base-specifically terminated fragments so as to be unique; and

wherein the molecular weight values of the nested fragments of two or more sets of unseparated base-specifically terminated fragments are determined concurrently.

40. The method according to claim 39, wherein the reversible linkage is a photocleavable bond.

41. The method according to claim 39, wherein the base-specifically terminated fragments are cleaved from the solid support prior to mass spectrometry.

42. The method according to claim 39, wherein the base-specifically terminated fragments are cleaved from the solid support during mass spectrometry.